Article 1
This set of Standards is formulated in accordance with the regulations of Article 10 of the Charge And Fees Act.
Article 2
This set of Standards applies to the biological products manufactured and commissioned for production by the Centers for Disease Control, Ministry of Health and Welfare.
Article 3
The biological products mentioned in this set of Standards are Antivenins.
Article 4
Items and fees charged for the manufactured and supplied biological products are as shown in the Attachment.
Article 5
This set of Standards shall enter into force on January 1, 2017.
The Attachment to Article 4 of these standards, amended on May 10, 2019, shall enter into force on July 1, 2019.